
Protekt Therapeutics
Company description
See translation
Protekt Therapeutics is a biopharmaceutical company aiming to identify and develop a potent and selective oral PKR inhibitor (PKRi) to treat cognitive disorders such as Alzheimers disease and mild cognitive impairment. PKR is a stress and proapoptotic ki...
HS code: {{pas.hsCode | limitTo: 23}}
Commercial information
Affiliations:
People in this company (1)
Contact this company through Start-Up Nation Central
To get in touch with the ConnectAmericas support team, please send an e-mail with your request to soporte@connectamericas.com and we will get back to you briefly.
Follow Us